Home Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
Article
Licensed
Unlicensed Requires Authentication

Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study

  • Simonetta Palleschi , Sandro De Angelis , Loretta Diana , Barbara Rossi , Vincenza Papa , Giancarlo Severini and Giorgio Splendiani
Published/Copyright: September 11, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 9

Abstract

Background: Oxidative stress (OS) is considered to play a major role in the development of end-stage renal disease (ESRD) complications. However, conflicting and inconsistent data have been reported on OS in ESRD patients. Our aim was to investigate the reliability of the most popular non-enzymatic plasma OS biomarkers in ESRD.

Methods: Vitamins A (VitA), E and C (VitC), uric acid, plasma antioxidant and ferric-reducing potential (PAP and PRP), thiols (SH), malondialdehyde (MDA) and lipid hydroperoxides (HPO) were determined before and after dialysis in plasma from 33 ESRD patients on hemodialysis, hemodiafiltration or peritoneal dialysis and 20 control subjects.

Results: In ESRD patients, high PRP and normal PAP values were positively correlated with VitC levels. After dialysis, PRP levels decreased, while unchanged PAP levels correlated positively with high VitA and transiently recovered SH values. All patients showed high levels of both MDA and cholesterol-normalized HPO. However, while the former significantly decreased after dialysis, the latter were unaffected by treatment. Paradoxical correlations of MDA with both VitA and HPO were found.

Conclusions: Plasma PRP and MDA levels may be dramatically affected by both uremia and dialysis; their use in ESRD patients may therefore lead to OS misevaluation and should be avoided. More reliable results can be obtained using physiologically relevant OS functional tests, such as PAP, and early biomarkers of OS damage, such as SH and HPO.

Clin Chem Lab Med 2007;45:1211–8.


Corresponding author: Simonetta Palleschi, PhD, Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy Phone: +39-06-49902776, Fax: +39-06-49902757,

Received: 2007-3-5
Accepted: 2007-5-21
Published Online: 2007-09-11
Published in Print: 2007-09-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. SIBioC 2007, 39th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Palacongressi Rimini (Italy), 2-5 October 2007
  2. Third “Biologie Prospective” Santorini Conference
  3. Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease
  4. Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients
  5. Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)
  6. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
  7. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
  8. Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
  9. Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
  10. Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems
  11. New perspectives and strategy research biomarkers for hepatocellular carcinoma
  12. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review
  13. The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
  14. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
  15. Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
  16. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
  17. Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
  18. The association between lipid profiles and breast cancer among Taiwanese women
  19. Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
  20. Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
  21. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
  22. Intra-individual variation in creatinine and cystatin C
  23. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention
  24. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination
  25. Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting
  26. Type B natriuretic peptide stability in frozen plasma
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.266/html
Scroll to top button